Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
107.50    -1.50 (-1.38%)
Bid:
105.00
Ask:
107.00
Spread: 2.00 (1.905%)
Market Cap: £105.94m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Update and Board Changes

12 May 2023 07:00

RNS Number : 1751Z
Eurocell plc
12 May 2023
 

12 May 2023

EUROCELL PLC

("Eurocell" or the "Group")

 

Trading Update and Board Changes

 

Eurocell plc, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, provides the following update for the first four months of 2023.

 

Trading Performance

Group sales for the four months to 30 April 2023 were down 2% compared to a very strong equivalent period in 2022. Comparisons by division were as follows:

 

Sales to 30 April 2023

vs 2022

Total Group

-2%

Profiles Division

level

Building Plastics Division

-3%

 

Whilst we have benefited from recent market share gains in Profiles, trading volumes for the Group were nonetheless down 6% in the period, impacted by weakness in both the repair, maintenance and improvement (RMI) and new build markets as follows: 

Profiles - subdued RMI and fragile new build markets have resulted in lower sales volumes. However, we have continued to acquire new fabricator accounts, and our pipeline of potential new fabricator customers remains healthy.

Building Plastics - RMI volume in the branch network is also subdued but remains steady.

We have continued to experience cost inflation, particularly for electricity (where we operate a rolling 12-month forward hedging policy for the majority of our requirements). PVC resin prices have fallen back slightly this year, but remain volatile, and feedstock prices for our recycling plants remain significantly higher than the comparative period in 2022.

 

We have continued to offset input cost inflation with selling price increases and surcharges. However, lower volumes and resin prices are driving increasingly competitive markets for our products, resulting in margin pressure.

 

Outlook and Seasonality

The Construction Product Association's (CPA) latest forecast, published earlier in May, reaffirmed a reduction in the RMI market of -9% for 2023 (unchanged from the January CPA update), but now predicts a further decline in new build to -17% (previously -11%), before both markets recover in 2024.

 

As market volumes and oil prices retreat, we have acted quickly and are capturing further cost savings. Also, driven by our increasingly efficient operations, we have identified additional opportunities for cost reduction and profit improvement.

 

Last year, in a change to historical seasonal patterns, sales volume and profit generation was weighted towards H1. This reflected very strong demand in the RMI market in the first half, followed by a slowdown in smaller discretionary RMI work in H2. For 2023, we now anticipate a heavy weighting towards H2, with sales returning to normal seasonality and profits in the second half also benefiting from lower input prices (including hedged electricity) and cost savings.

 

Taking the above factors into account, we now expect adjusted profit before tax for 2023 to come in below current market expectations (1).

 

Our balance sheet is strong and the actions we have taken and plan to implement will improve our efficiency and resilience, and position us well to benefit when our end markets recover.

 

Board Changes

The following Board changes took place following the conclusion of yesterday's AGM.

 

As previously announced, following an agreed handover period, Darren Waters assumed the position of Chief Executive Officer and Mark Kelly retired. Also as previously announced, Martyn Coffey stood down from the Board.

 

We are also delighted to announce that the Board appointed Will Truman as an independent Non-executive Director, and member of the Nomination Committee.

 

Will brings strong commercial expertise, as well as a wealth of experience in stakeholder management and M&A. He is currently engaged in a non-executive advisory role at Imagesound Limited, having served as Chief Executive Officer for 9 years up to April 2023, and as Chief Financial Officer for 7 years prior to that. Previously, Will was an Associate Director in Transaction Services at KPMG LLP and is a Fellow of the Institute of Chartered Accountants in England and Wales.

 

Derek Mapp, Chair of the Board, said:

 

"I am delighted that Will is joining the Eurocell Board. He brings extensive and complementary experience of delivering sustainable business growth, both organically and through acquisition, and we are looking forward to working with him."

 

This announcement is made pursuant to LR 9.6.11R(3) of the Listing Rules and there are no further matters, required by paragraphs 9.6.13R (1) to (6) of the Listing Rules, to be disclosed in relation to Will Truman.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Notes:

(1) Eurocell-calculated analyst consensus profit before tax forecast for 2023 of £22.0 million.

 

Enquiries:

Eurocell plc

Darren Waters, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

 

Teneo

Nick de Bunsen +44 (0) 7825 575 258

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLTEFILLIV
Date   Source Headline
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
7th Mar 20237:00 amRNSBlock listing Interim Review
3rd Feb 20237:00 amRNSNon-executive Directors' Share Purchase Plan
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSYear End Trading Update
6th Jan 20237:00 amRNSCEO Announces Intention to Retire in 2023
15th Nov 20227:04 amRNSHolding(s) in Company
14th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:59 pmRNSDirectorate Change
26th Oct 20227:00 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSChanges to Board Committee memberships
5th Oct 20222:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
5th Sep 20227:00 amRNSBlock listing Interim Review
5th Sep 20227:00 amRNSInvestor Presentation
1st Sep 20227:00 amRNSHalf-year Report
15th Aug 20223:00 pmRNSHolding(s) in Company
10th Aug 20223:45 pmRNSAppointment to the Audit & Risk Committee
13th Jul 20227:00 amRNSTrading Update
5th Jul 202212:25 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
21st Jun 202212:08 pmRNSDirectorate Change
25th May 20227:00 amRNSBlock Listing Application
16th May 20227:00 amRNSDirector/PDMR Shareholding
12th May 20224:00 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update and Board Update
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
21st Mar 20227:00 amRNSInvestor Presentation
18th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Mar 20227:00 amRNSNotice of Results and Audiocast
15th Mar 20223:05 pmRNSTransaction in Own Shares
9th Mar 20225:00 pmRNSBlock listing Interim Review
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
21st Jan 20227:00 amRNSYear End Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Update November 2021
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
7th Sep 20214:00 pmRNSInvestor Presentation
7th Sep 20211:38 pmRNSBlock listing Interim Review
3rd Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20217:00 amRNSTrading Update
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.